Downregulation of cytochromes P450 in growth-stimulated rat hepatocytes: Role of c-Myc induction and impaired C/EBP binding to DNA

Journal of Hepatology

Volumn 39, Issue 2, 2003, Pages 171-178

  Tinel, Marina ^a   Berson, Alain ^a   Elkahwaji, Johny ^a   Cresteil, Thierry ^b   Beaune, Philippe ^c   Pessayre, Dominique ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b CNRS   (France)

^c INSERM   (France)

Author keywords

c Myc; CCAAT enhancer binding protein; Cell differentiation; Cell growth; CYP; Cytochrome P450; Epidermal growth factor

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CCAAT ENHANCER BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; CELL PROTEIN; CYTOCHROME P450; DIMETHYL SULFOXIDE; DNA; EPIDERMAL GROWTH FACTOR; MESSENGER RNA; MONOCLONAL ANTIBODY; MYC PROTEIN; NUCLEAR PROTEIN; OLIGOMER; RETINOIC ACID;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; BINDING ASSAY; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL STIMULATION; COMPLEX FORMATION; CONFERENCE PAPER; CONTROLLED STUDY; DNA PROBE; DOWN REGULATION; ENZYME REGULATION; GEL MOBILITY SHIFT ASSAY; GENE INDUCTION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; IMMUNOPRECIPITATION; LIVER CELL; MALE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

EID: 0042671351     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(03)00238-1     Document Type: Conference Paper

References (37)

1. Höhne M, Becker-Rabbenstein V, Kahl GF, Taniguchi H. Regulation of cytochrome P-450 CYP1A1 gene expression and protooncogene expression by growth factors in primary hepatocytes. FEBS Lett 1990;273:219-22.
2. Ching KZ, Tanney KA, Chen J, Morgan ET. Suppression of constitutive cytochrome P450 gene expression by epidermal growth factor receptor ligands in cultured rat hepatocytes. Drug Metab Dispos 1996;24:542-6.
3. Gruet J, Pichard L, Ourlin JC, Bonfils C, Domergue J, Le Truet P, Maurel P. Effect of cell density and epidermal growth factor on the inducible expression of CYP3A and CYP1A genes in human hepatocytes in primary culture. Hepatology 1997;25:1166-75.
4. Garcia MC, Thangavel CJ, Shapiro BH. Epidermal growth factor regulation of female-dependent CYP2A1 and CYP2C12 in primary rat hepatocyte culture. Drug Metab Dispos 2001;29:111-9.
5. Tinel M, Elkahwaji J, Robin MA, Fardel N, Descatoire V, Haouzi D, et al. Interleukin-2 overexpresses c-myc and down-regulates cytochrome P-450 in rat hepatocytes. J Pharmacol Exp Ther 1999;289:649-55.
6. Michalopoulos GK. Liver regeneration: molecular mechanisms of growth control. FASEB J 1990;4:176-84.
7. Runge DM, Runge D, Dorko K, Pisarov LA, Leckel K, Kostrubsky VE, et al. Epidermal growth factor- and hepatocyte growth factor-receptor activity in serum-free cultures of human hepatocytes. J Hepatol 1999;30:265-74.
8. Kholodenko BN, Demin OV, Moehren G, Hoek JB. Quantification of short term signaling by the epidermal growth factor receptor. J Biol Chem 1999;274:30169-81.
9. Kerkhoff E, Houben R, Löffler S, Troppmair J, Lee JE, Rapp UR. Regulation of c-myc expression by Ras/Raf signalling. Oncogene 1998;16:211-6.
10. Izadnegahdar MF, Rathanaswami P, Shah RM. Effects of EGF and TGFβ1 on c-myc gene expression and DNA synthesis in embryonic hamster palate mesenchymal cells. Anat Record 1999;254:453-64.
11. Grandori C, Cowley SM, James LP, Eisenman RN. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol 2000;16:653-99.
12. Mink S, Mutschler B, Weiskirchen R, Bister K, Klemnauer KH. A novel fonction for Myc: Inhibition of C/EBP-dependent gene activation. Proc Natl Acad Sci USA 1996;93:6635-40.
13. Takigushi M. The C/EBP family of transcription factors in the liver and others organs. Int J Exp Pathol 1998;79:369-91.
14. Müller C, Alunni-Fabbroni M, Kowenz-Leutz E, Mo X, Tommasino M, Leutz A. Separation of C/EBPα-mediated proliferation arrest and differentiation pathways. Proc Natl Acad Sci USA 1999;96:7276-81.
15. Tao H, Umek RM. Reciprocal regulation of gadd45 by C/EBPα and c-Myc. DNA Cell Biol 1999;18:75-84.
16. Facchini LM, Penn LZ. The molecular role of Myc in growth and transformation: recent discoveries lead to new insights. FASEB J 1998;12:633-51.
17. Luc PV, Adesnik M, Ganguly S, Shaw PM. Transcriptional regulation of the CYP2B1 and CYP2B2 genes by C/EBP-related proteins. Biochem Pharmacol 1996;51:345-56.
18. Ström A, Eguchi H, Mode A, Legraverend C, Tollet P, Strömstedt PE, Gustafsson JA. Characterization of proximal promoter and two silencer elements in the CYP2C11 gene expressed in rat liver. DNA Cell Biol 1994;13:805-19.
19. Tollet P, Lahuna O, Ahlgren R, Mode A, Gustafsson JA. CCAAT/enhancer binding protein-α-dependent transactivation of CYP2C12 in rat hepatocytes. Mol Endocrinol 1995;9:1171-81.
20. Lee YH, Yano M, Matsunaga E, Johnson PF, Gonzalez FJ. A novel cis-acting element controlling the rat CYP2D5 gene and requiring cooperativity between C/EBP beta and an SP1 factor. Mol Cell Biol 1994;14:1383-94.
21. Jover R, Bort R, Gomez-Lechon MJ, Castell JV. Re-expression of C/EBPα induces CYP2B6, CYP2C9, and CYP2D6 genes in HepG2 cells. FEBS Lett 1998;431:227-30.
22. Ourlin JC, Jounaidi Y, Maurel P, Vilarem MJ. Role of the liver-enriched transcription factors C/EBPα and DBP in the expression of human CYP3A4 and CYP3A7. J Hepatol 1996;26(Suppl 2):54-62.
23. Arora V, Knapp DC, Smith BL, Statdfield ML, Stein DA, Reddy MT, et al. c-Myc antisense limits rat liver regeneration and indicates role for c-Myc in regulating cytochrome P-450 3A activity. J Pharmacol Exp Ther 2000;292:921-8.
24. Hayashi K, Makino R, Kawamura H, Arisawa A, Yoneda K. Characterisation of rat c-myc and adjacent regions. Nucleic Acids Res 1987;15:6419-36.
25. Hamamoto R, Yamada K, Kamihira M, Iijima S. Differentiation and proliferation of primary rat hepatocytes cultured as spheroides. J Biol Chem 1998;124:972-9.
26. Tinel M, Robin MA, Doostzadeh J, Maratrat M, Ballet F, Fardel N, et al. The interleukin-2 receptor down-regulates the expression of cytochrome P450 in cultured rat hepatocytes. Gastroenterology 1995;109:1589-99.
27. Cresteil T, Jaiswal AK, Eisen HJ. Transcriptional control of human cytochrome P1-450 gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin in human tissue culture cell lines. Arch Biochem Biophys 1987;253:233-40.
28. Schreiber EH, Matthias P, Muller MM, Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts' prepared from small number of cells. Nucleic Acid Res 1989;17:6419.
29. Westin EH, Wong-Staal F, Gelmann EP, Favera RD, Papas T, Lautenberger JA, et al. Expression of cellular homologues of retroviral onc genes in human hematopoeitic cells. Proc Natl Acad Sci USA 1982;79:2490-4.
30. Dony C, Kessel M, Gruss P. Post-transcriptional control of myc and p53 expression during differentiation of the embryonal carcinoma cell line F9. Nature 1985;317:636-9.
31. Krumm A, Meulia T, Brunvand M, Goudine M. The block to transcriptional elongation within the human c-myc gene is determined in the promoter-proximal region. Genes Dev 1992;6:2201-13.
32. Strobl LJ, Eick D. Hold back of RNA polymerase II at the transcription start site mediates down-regulation of c-myc in vivo. EMBO J 1992;11:3307-14.
33. Landschulz WH, Johnson PF, Adashi EY, Graves BJ, McKnight SL. Isolation of a recombinant copy of the gene encoding C/EBP. Gene Dev 1998;2:786-800.
34. Descombes P, Schibler U. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 1991;67:569-79.
35. Hudziak RM, Summerton J, Weller DD, Iversen PL. Antiproliferative effects of steric blocking phosphorodiamidate morpholino antisense agents directed against c-myc. Antisense Nucl Acid Drug Dev 2000;10:163-76.
36. Yaswen P, Stampfer MR, Ghosh K, Cohen JS. Effects of sequence of thioated oligonucleotides on cultured human mammary epithelial cells. Antisense Res Dev 1993;3:67-77.
37. Burgess TL, Fisher EF, Ross SL, Bready JV, Qian YX, Bayewitch LA, et al. The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism. Proc Natl Acad Sci USA 1995;92:4051-5.